NCT05586152View on ClinicalTrials.gov

Study of INV-102 Ophthalmic Solution in Adults With Moderate Symptomatic Dry Eye Disease

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

August 30, 2022

Primary Completion Date

May 2, 2023

Study Completion Date

May 2, 2023

Conditions
Dry Eye Disease
Interventions
DRUG

INV-102

INV-102 Ophthalmic Solution

DRUG

Vehicle

Vehicle Ophthalmic Solution

Trial Locations (1)

14543

iuvo BioScience, Rush

Sponsors

Lead Sponsor

Invirsa, Inc.
All Listed Sponsors
collaborator

Biomedical Advanced Research and Development Authority

FED

lead

Invirsa, Inc.

INDUSTRY